These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31053475)

  • 1. Safety of artificial pancreas in hepato-biliary-pancreatic surgery: A prospective study.
    Hayashi H; Tajima H; Hanazaki K; Takamura H; Gabata R; Okazaki M; Ohbatake Y; Nakanuma S; Makino I; Miyashita T; Ninomiya I; Fushida S; Yoshimura K; Ohta T
    Asian J Surg; 2020 Jan; 43(1):201-206. PubMed ID: 31053475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of perioperative glucose metabolism using an artificial pancreas.
    Okazaki M; Hayashi H; Gabata R; Ohbatake Y; Shinbashi H; Nakanuma S; Makino I; Tajima H; Takamura H; Ohta T
    Artif Organs; 2021 Sep; 45(9):998-1005. PubMed ID: 33819346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative tight glycemic control using artificial pancreas decreases infectious complications via suppression of inflammatory cytokines in patients who underwent pancreaticoduodenectomy: A prospective, non-randomized clinical trial.
    Akabori H; Tani M; Kitamura N; Maehira H; Imashuku Y; Tsujita Y; Shimizu T; Kitagawa H; Eguchi Y
    Am J Surg; 2020 Aug; 220(2):365-371. PubMed ID: 31836178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system: the effects of no hypoglycemia.
    Hanazaki K; Kitagawa H; Yatabe T; Munekage M; Dabanaka K; Takezaki Y; Tsukamoto Y; Asano T; Kinoshita Y; Namikawa T
    Am J Surg; 2014 Jun; 207(6):935-41. PubMed ID: 24480234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between a novel and conventional artificial pancreas for perioperative glycemic control using a closed-loop system.
    Namikawa T; Munekage M; Kitagawa H; Yatabe T; Maeda H; Tsukamoto Y; Hirano K; Asano T; Kinoshita Y; Hanazaki K
    J Artif Organs; 2017 Mar; 20(1):84-90. PubMed ID: 27651347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the optimal range of glycemic control for non-diabetic patients undergoing gastroenterological surgery? A single-center randomized controlled trial using an artificial pancreas.
    Tanioka N; Maeda H; Uemura S; Munekage M; Kitagawa H; Namikawa T; Kuroiwa H; Fujimoto S; Seo S; Hanazaki K
    Artif Organs; 2023 Jun; 47(6):943-950. PubMed ID: 37084125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: a prospective randomized clinical trial.
    Okabayashi T; Nishimori I; Yamashita K; Sugimoto T; Maeda H; Yatabe T; Kohsaki T; Kobayashi M; Hanazaki K
    Arch Surg; 2009 Oct; 144(10):933-7. PubMed ID: 19841361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of perioperative intensive insulin therapy for liver dysfunction after hepatic resection.
    Okabayashi T; Ichikawa K; Namikawa T; Sugimoto T; Kobayashi M; Hanazaki K
    World J Surg; 2011 Dec; 35(12):2773-8. PubMed ID: 21976008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Artificial Pancreas in Liver Transplant Recipients: Preliminary Experience with an Insightful Message.
    Hayashi H; Takamura H; Gabata R; Makino I; Ohbatake Y; Nakanuma S; Miyashita T; Tajima H; Hanazaki K; Ohta T
    Ann Transplant; 2017 Oct; 22():590-597. PubMed ID: 28970466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tight perioperative glycemic control using an artificial endocrine pancreas.
    Hanazaki K; Maeda H; Okabayashi T
    Surg Today; 2010; 40(1):1-7. PubMed ID: 20037833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of an artificial pancreas device for achieving tight perioperative glycemic control in living donor liver transplantation.
    Soyama A; Kugiyama T; Hara T; Hidaka M; Hamada T; Okada S; Adachi T; Ono S; Takatsuki M; Eguchi S
    Artif Organs; 2019 Mar; 43(3):270-277. PubMed ID: 30332505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory effects of perioperative intensive insulin therapy during cardiac surgery with cardiopulmonary bypass.
    Hasegawa A; Iwasaka H; Hagiwara S; Koga H; Hasegawa R; Kudo K; Kusaka J; Noguchi T
    Surg Today; 2011 Oct; 41(10):1385-90. PubMed ID: 21922361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tight glycemic control using an artificial endocrine pancreas may play an important role in preventing infection after pancreatic resection.
    Hanazaki K
    World J Gastroenterol; 2012 Aug; 18(29):3787-9. PubMed ID: 22876028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of perioperative glucose control by using an artificial pancreas in a patient with glycogen storage disease.
    Yatabe T; Nakamura R; Kitagawa H; Munekage M; Hanazaki K
    J Artif Organs; 2016 Mar; 19(1):100-3. PubMed ID: 26194122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of perioperative glycemic control using an artificial endocrine pancreas.
    Hanazaki K; Namikawa T
    Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():5719-22. PubMed ID: 24111036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative glycemic control using an artificial endocrine pancreas in patients undergoing total pancreatectomy: tight glycemic control may be justified in order to avoid brittle diabetes.
    Hanazaki K; Yatabe T; Kobayashi M; Tsukamoto Y; Kinoshita Y; Munekage M; Kitagawa H
    Biomed Mater Eng; 2013; 23(1-2):109-16. PubMed ID: 23442241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strict blood glucose control by an artificial endocrine pancreas during hepatectomy may prevent postoperative acute kidney injury.
    Mita N; Kawahito S; Soga T; Takaishi K; Kitahata H; Matsuhisa M; Shimada M; Kinoshita H; Tsutsumi YM; Tanaka K
    J Artif Organs; 2017 Mar; 20(1):76-83. PubMed ID: 27557726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The optimal blood glucose target in critically ill patient: comparison of two intensive insulin therapy protocols].
    Raurell Torredà M; del Llano Serrano C; Almirall Solsona D; Catalan Ibars RM; Nicolás Arfelis JM
    Med Clin (Barc); 2014 Mar; 142(5):192-9. PubMed ID: 23490488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of an Artificial Pancreas System for Young Children with Type 1 Diabetes.
    DeBoer MD; Breton MD; Wakeman C; Schertz EM; Emory EG; Robic JL; Kollar LL; Kovatchev BP; Cherñavvsky DR
    Diabetes Technol Ther; 2017 May; 19(5):293-298. PubMed ID: 28426239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status and issues of the artificial pancreas: abridged English translation of a special issue in Japanese.
    Namikawa T; Munekage M; Yatabe T; Kitagawa H; Hanazaki K
    J Artif Organs; 2018 Jun; 21(2):132-137. PubMed ID: 29356912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.